The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

The company joins a group of degrader ADC (or DAC) developers that includes Bristol Myers Squibb and Pfizer.

An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA ...

Researchers at Nano Life Science Institute (WPI-NanoLSI) and the Cancer Research Institute at Kanazawa University have ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

Jan 22 (Reuters) - Corcept Therapeutics said on Thursday a late-stage trial showed its experimental drug in combination with ...

The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...

The U.S. Food and Drug Administration (FDA) has granted full approval of Laverdia, a drug to treat dogs with lymphoma, a type ...

Pharmaceuticals giant, Merck & Co. Inc. (NYSE: MRK), is reportedly in talks to acquire cancer drug-maker Revolution Medicines Inc. (NASDAQ: RVMD) in a deal potentially valued at between $28 and $32 ...

BioNTech SE is flexible about its future structure as it prepares to bring a slew of cancer drugs to market, with its chief executive officer saying he would consider a deal with a partner that gets ...

Proton pump inhibitors are among the most commonly prescribed medications worldwide, but concerns about a possible link to ...